network member

Novant Health Oncology Specialists

Winston-Salem, NC

About Network Member

Website: Novant Health Oncology Specialists

https://www.novanthealth.org/clinic-locations/novant-health-oncology-specialists---winston-salem.aspx

Currently Enrolling

HCRN-BRE21-516

BRIDGET: Secondary BRain metastases prevention after Isolated intracranial progression on Trastuzumab/Pertuzumab or T-DM1 in patients with aDvanced human epidermal Growth factor receptor 2+ brEast cancer with the addition of Tucatinib

Cancer areas:Breast

Dana-Farber Cancer Institute

Duke Cancer Institute

MD Anderson Cancer Center

Novant Health Oncology Specialists

Providence Cancer Institute

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

The Ohio State University

UC San Francisco

University of Michigan Rogel Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-BRE18-334

A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)

Bryan P. Schneider

Cancer areas:Breast

Advocate Aurora Research Institute (Illinois)

Aurora Health Care

Froedtert & the Medical College of Wisconsin

Georgetown Lombardi Comprehensive Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Miami Cancer Institute at Baptist Health, Inc.

Novant Health Oncology Specialists

The University of Chicago Medicine Comprehensive Cancer Center

University of Alabama at Birmingham Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

UT Health San Antonio MD Anderson Cancer Center

See clinicaltrials.gov